These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7917769)

  • 1. Fixed combinations of neuroleptics with antidepressants: potential risks and estimation of use.
    Llerena A; Kiivet RA
    Br J Clin Pharmacol; 1994 Jun; 37(6):531-2. PubMed ID: 7917769
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug metabolism and psychiatry: introduction.
    Baker GB
    Cell Mol Neurobiol; 1999 Jun; 19(3):301-8. PubMed ID: 10319189
    [No Abstract]   [Full Text] [Related]  

  • 3. Interethnic differences in drug oxidation. Implications for the utilization of antidepressants and neuroleptics.
    Dahl ML; Johansson I; Yue QY; Säwe J; Bertilsson L; Ingelman-Sundberg M; Sjöqvist F
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():88A-89A. PubMed ID: 1354075
    [No Abstract]   [Full Text] [Related]  

  • 4. Appropriate use of neuroleptics and antidepressants in the geriatric patient.
    Cancellaro LA
    South Med J; 1991 May; 84(5 Suppl 1):S53-6. PubMed ID: 1674628
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics.
    Dahl ML; Sjöqvist F
    Ther Drug Monit; 2000 Feb; 22(1):114-7. PubMed ID: 10688272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common drug interactions following traumatic brain injury.
    Levine JM
    J Head Trauma Rehabil; 2013; 28(2):151-4. PubMed ID: 23466826
    [No Abstract]   [Full Text] [Related]  

  • 7. [Characteristics of the interaction of neuroleptics and antidepressants with plasma proteins (review of the literature)].
    Bender KI; Kupchikov VV; Lutsevich AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):116-24. PubMed ID: 1686128
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antidepressant pharmacokinetics during pregnancy].
    Maslovskiĭ SIu
    Eksp Klin Farmakol; 2013; 76(1):14-20. PubMed ID: 23461010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
    Kirchheiner J; Nickchen K; Bauer M; Wong ML; Licinio J; Roots I; Brockmöller J
    Mol Psychiatry; 2004 May; 9(5):442-73. PubMed ID: 15037866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Debrisoquin and mephenytoin hydroxylation phenotypes and CYP2D6 genotype in patients treated with neuroleptic and antidepressant agents.
    LLerena A; Herraíz AG; Cobaleda J; Johansson I; Dahl ML
    Clin Pharmacol Ther; 1993 Dec; 54(6):606-11. PubMed ID: 7903915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing risks: dosing strategies for antidepressants near the end of pregnancy.
    Miller LJ; Bishop JR; Fischer JH; Geller SE; Macmillan C
    J Clin Psychiatry; 2008 Feb; 69(2):323-4. PubMed ID: 18363456
    [No Abstract]   [Full Text] [Related]  

  • 12. The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants.
    Sjöqvist F; Eliasson E
    Clin Pharmacol Ther; 2007 Jun; 81(6):899-902. PubMed ID: 17392719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood level monitoring of antipsychotics and antidepressants.
    Javaid JI; Janicak PG; Holland D
    Psychiatr Med; 1991; 9(1):163-87. PubMed ID: 1673256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review.
    Bigos KL; Pollock BG; Stankevich BA; Bies RR
    Gend Med; 2009 Dec; 6(4):522-43. PubMed ID: 20114004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants.
    Saiz-Rodríguez M; Belmonte C; Román M; Ochoa D; Jiang-Zheng C; Koller D; Mejía G; Zubiaur P; Wojnicz A; Abad-Santos F
    Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):474-485. PubMed ID: 29723928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terbinafine and potential drug interactions.
    Kaplan DL
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):882-4. PubMed ID: 11050604
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy.
    Altar CA; Hornberger J; Shewade A; Cruz V; Garrison J; Mrazek D
    Int Rev Psychiatry; 2013 Oct; 25(5):509-33. PubMed ID: 24151799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic drug monitoring of new antidepressives and antipsychotics].
    Härtter S; Hiemke C
    Med Monatsschr Pharm; 2003 May; 26(5):160-2. PubMed ID: 12784506
    [No Abstract]   [Full Text] [Related]  

  • 19. Distribution interactions between perazine and antidepressant drugs. In vivo studies.
    Wójcikowski J; Daniel WA
    Pol J Pharmacol; 2000; 52(6):449-57. PubMed ID: 11334238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics-guided dose modifications of antidepressants.
    Seeringer A; Kirchheiner J
    Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.